These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37761997)

  • 1. In the Search for Biomarkers of Pulmonary Arterial Hypertension, Are Cytokines IL-2, IL-4, IL-6, IL-10, and IFN-Gamma the Right Indicators to Use?
    Tomaszewski M; Mertowska P; Janczewska M; Styczeń A; Mertowski S; Jonas K; Grywalska E; Kopeć G
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37761997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
    Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
    J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH.
    Åberg M; Björklund E; Wikström G; Christersson C
    Platelets; 2022 Nov; 33(8):1199-1207. PubMed ID: 35701864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of type I interferon in pulmonary arterial hypertension.
    George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA
    Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension.
    Gugliandolo E; Macrì F; Fusco R; Siracusa R; Cordaro M; D'amico R; Peritore AF; Impellizzeri D; Genovese T; Cuzzocrea S; Di Paola R; Crupi R
    Pharmacol Res; 2023 Jun; 192():106750. PubMed ID: 37004831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
    Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
    Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrophages in pulmonary arterial hypertension.
    Zhang MQ; Wang CC; Pang XB; Shi JZ; Li HR; Xie XM; Wang Z; Zhang HD; Zhou YF; Chen JW; Han ZY; Zhao LL; He YY
    Front Immunol; 2023; 14():1152881. PubMed ID: 37153557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.
    Christmann RB; Hayes E; Pendergrass S; Padilla C; Farina G; Affandi AJ; Whitfield ML; Farber HW; Lafyatis R
    Arthritis Rheum; 2011 Jun; 63(6):1718-28. PubMed ID: 21425123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.
    Tomaszewski M; Małkowska P; Sierawska O; Hrynkiewicz R; Mroczek E; Darocha S; Hymos A; Błaszczak P; Grywalska E; Niedźwiedzka-Rystwej P
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and diagnostic utility of interleukin-6 in pediatric pulmonary arterial hypertension - a case-control study.
    Megied MAAE; Abouelhassan MA; Hadwa ESAES
    Eur J Pediatr; 2024 Apr; 183(4):1637-1643. PubMed ID: 38193997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An upregulation of CD8
    Zhu R; Chen L; Xiong Y; Wang N; Xie X; Hong Y; Meng Z
    Exp Cell Res; 2017 Sep; 358(2):182-187. PubMed ID: 28648519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
    Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
    Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Tu J; Jin J; Chen X; Sun L; Cai Z
    Front Immunol; 2022; 13():868983. PubMed ID: 35663995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
    Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
    Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension.
    Soon E; Holmes AM; Treacy CM; Doughty NJ; Southgate L; Machado RD; Trembath RC; Jennings S; Barker L; Nicklin P; Walker C; Budd DC; Pepke-Zaba J; Morrell NW
    Circulation; 2010 Aug; 122(9):920-7. PubMed ID: 20713898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1.
    Mumby S; Perros F; Grynblat J; Manaud G; Papi A; Casolari P; Caramori G; Humbert M; John Wort S; Adcock IM
    Respir Res; 2023 Jul; 24(1):193. PubMed ID: 37516840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.